Cariprazine Relative to Placebo in the Prevention of Relapse of Symptoms in Patients With Schizophrenia
|ClinicalTrials.gov Identifier: NCT01412060|
Recruitment Status : Completed
First Posted : August 8, 2011
Last Update Posted : September 30, 2015
Gedeon Richter Ltd.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||August 2014|
|Actual Study Completion Date :||November 2014|
|Certification/Extension First Submitted :||September 25, 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Durgam S, Earley W, Li R, Li D, Lu K, Laszlovszky I, Fleischhacker WW, Nasrallah HA. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial. Schizophr Res. 2016 Oct;176(2-3):264-271. doi: 10.1016/j.schres.2016.06.030. Epub 2016 Jul 15. Erratum in: Schizophr Res. 2018 Feb;192:493.